CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/Lymphoma

Clinical trial NCT05613348 · WITHDRAWN

Trial details

NCT number: NCT05613348
Sponsor: Zhujiang Hospital
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia B-Cell Lymphoma, Unspecified

Start date: 2022-12-01
Primary completion: 2025-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.